Hyuk Sung Kwon Selected Research

Biomarkers (Surrogate Marker)

10/2023	Predicting cognitive stage transition using p-tau181, Centiloid, and other measures.
10/2023	Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers.
1/2022	Serum neurofilament light chain level as a predictor of cognitive stage transition.
11/2020	Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
3/2015	Increased VEGF and decreased SDF-1α in patients with silent brain infarction are associated with better prognosis after first-ever acute lacunar stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyuk Sung Kwon Research Topics

Disease

5	Dementia (Dementias) 10/2023 - 08/2020
4	Stroke (Strokes) 02/2023 - 01/2021
4	Ischemic Stroke 07/2021 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 08/2020
3	Cognitive Dysfunction 10/2023 - 03/2020
3	Hypoxia (Hypoxemia) 03/2013 - 07/2011
2	Neuroinflammatory Diseases 01/2024 - 11/2020
2	Gout 02/2023 - 01/2023
2	Neoplasms (Cancer) 09/2019 - 08/2012
1	Vertebral Artery Dissection 01/2024
1	Infarction (Infarctions) 01/2024
1	Hypertension (High Blood Pressure) 02/2023
1	Motor Neuron Disease (Primary Lateral Sclerosis) 02/2023
1	Diabetes Complications 02/2023
1	Dyslipidemias (Dyslipidemia) 02/2023
1	COVID-19 09/2022
1	Encephalitis (Encephalitis, Rasmussen) 09/2022
1	Ovarian Teratoma 09/2022
1	Reperfusion Injury 09/2021
1	Brain Ischemia (Cerebral Ischemia) 09/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Hemorrhagic Stroke 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020
1	Tolosa-Hunt Syndrome 04/2020
1	painful Ophthalmoplegia 04/2020
1	Cerebral Hemorrhage 03/2020
1	Patent Foramen Ovale 01/2018
1	Brain Infarction 03/2015
1	Lacunar Stroke 03/2015

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2015
3	Oxygen (Dioxygen)IBA 09/2021 - 07/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 08/2012
2	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2024
1	Amyloid beta-PeptidesIBA 10/2023
1	Uric Acid (Urate)IBA 02/2023
1	Febuxostat FDA Link 01/2023
1	Allopurinol (Remid)FDA LinkGeneric 01/2023
1	SteroidsIBA 01/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2022
1	Neuroprotective AgentsIBA 09/2021
1	Glucose (Dextrose)FDA LinkGeneric 09/2021
1	Immunoglobulin G (IgG)IBA 07/2021
1	Antiphospholipid AntibodiesIBA 07/2021
1	Escitalopram FDA Link 05/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Donepezil (Aricept)FDA LinkGeneric 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 04/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2020
1	Cilostazol (Pletal)FDA LinkGeneric 03/2020
1	C-Reactive ProteinIBA 09/2019
1	HMGB1 Protein (HMG1)IBA 03/2015
1	Macrophage Migration-Inhibitory FactorsIBA 03/2015
1	Peptides (Polypeptides)IBA 03/2013
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	Proline (L-Proline)FDA Link 03/2013
1	Messenger RNA (mRNA)IBA 03/2013
1	Transcription Factors (Transcription Factor)IBA 03/2013
1	ElonginIBA 03/2013
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 07/2011

Therapy/Procedure

5	Therapeutics 01/2021 - 08/2012
1	Salpingo-oophorectomy 09/2022
1	Patient Care 01/2022
1	Activities of Daily Living (ADL) 01/2021
1	Secondary Prevention 01/2021
1	Medical Day Care (Partial Hospitalization) 08/2020
1	Cognitive Training 08/2020
1	Thrombectomy 09/2019